Michał Orczykowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michał Orczykowski has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ewa Świerżyńska-Wodarska
1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland
3 shared publications - Maciej Sterliński
1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland
3 shared publications - Łukasz Szumowski
1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland
3 shared publications - Rafał Dąbrowski
Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, Poland
2 shared publications - Anna Jargieło
1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland
1 shared publication - Anna Wałachowska
Students’ Scientific Society, National Institute of Cardiology, 04-628 Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (10) , 492
From Diagnosis to Treatment of Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction
Mitral valve prolapse (MVP) and mitral annular disjunction (MAD) are common comorbidities that can lead to serious cardiac arrhythmias and sudden cardiac death (SCD). Arrhythmic MVP is characterized by the presence of MVP with frequent (over 5% ventricular extra beats) and/or complex ventricular arrhythmias, such as ventricular tachycardia (VT), non-sustained VT, or ventricular fibrillation in the absence of other causes of arrhythmia, e.g., post-infarction scar, recent ischemia, channelopathy, or cardiomyopathy. The mechanisms of the development of serious cardiac arrhythmias in patients with MVP and MAD are not fully understood. Arrhythmic MVP may be an indication for cardioverter defibrillator implantation. Considering the increased risk of SCD in this group of patients, the pathophysiology of this valvular dysfunction and characteristic deviations in diagnostic tests that indicate a higher risk of SCD are presented. The issue of tailored risk stratification in individual patients is crucial.
- 1 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (10) , 492
Open AccessFrom Diagnosis to Treatment of Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction
Mitral valve prolapse (MVP) and mitral annular disjunction (MAD) are common comorbidities that can lead to serious cardiac arrhythmias and sudden cardiac death (SCD). Arrhythmic MVP is characterized by the presence of MVP with frequent (over 5% ventricular extra beats) and/or complex ventricular arrhythmias, such as ventricular tachycardia (VT), non-sustained VT, or ventricular fibrillation in the absence of other causes of arrhythmia, e.g., post-infarction scar, recent ischemia, channelopathy, or cardiomyopathy. The mechanisms of the development of serious cardiac arrhythmias in patients with MVP and MAD are not fully understood. Arrhythmic MVP may be an indication for cardioverter defibrillator implantation. Considering the increased risk of SCD in this group of patients, the pathophysiology of this valvular dysfunction and characteristic deviations in diagnostic tests that indicate a higher risk of SCD are presented. The issue of tailored risk stratification in individual patients is crucial.
- Open Access
Left Atrial Structural and Functional Changes After Pulmonary Vein Isolation Using Different Energy Sources
Background: Pulmonary vein isolation (PVI) is an established treatment for atrial fibrillation (AF); however, its impact on long-term left atrial (LA) structural and mechanical remodeling may differ between ablation techniques. Objectives: The aim of this study is to assess changes in LA structure and function after PVI using cryoballoon ablation (CBA) and radiofrequency catheter ablation (RFCA). Methods: Forty-two patients undergoing PVI were prospectively analyzed (CBA, n = 28; RFCA, n = 14). Transthoracic echocardiography with speckle-tracking analysis was performed before PVI and at 12-month follow-up. LA size, volumetric indices (LAVI), strain components, and functional parameters were assessed. Results: Patients undergoing CBA demonstrated greater increases in selected LA structural parameters during follow-up compared with RFCA. Repeated-measures ANOVA revealed a significant group-by-time interaction for LA diameter (p = 0.0017), while similar trends were observed for LAA (p = 0.0645) and LAS-R (p = 0.0547). No significant interaction effects were observed for LAVI-derived parameters or other indices of LA mechanical function. Conclusions: In this preliminary exploratory study, CBA showed a tendency toward greater structural LA remodeling compared with RFCA during a 12-month follow-up. However, these findings should be interpreted with caution given the limited sample size and population heterogeneity. Larger prospective studies are warranted to validate these observations.
Open AccessLeft Atrial Structural and Functional Changes After Pulmonary Vein Isolation Using Different Energy Sources
Background: Pulmonary vein isolation (PVI) is an established treatment for atrial fibrillation (AF); however, its impact on long-term left atrial (LA) structural and mechanical remodeling may differ between ablation techniques. Objectives: The aim of this study is to assess changes in LA structure and function after PVI using cryoballoon ablation (CBA) and radiofrequency catheter ablation (RFCA). Methods: Forty-two patients undergoing PVI were prospectively analyzed (CBA, n = 28; RFCA, n = 14). Transthoracic echocardiography with speckle-tracking analysis was performed before PVI and at 12-month follow-up. LA size, volumetric indices (LAVI), strain components, and functional parameters were assessed. Results: Patients undergoing CBA demonstrated greater increases in selected LA structural parameters during follow-up compared with RFCA. Repeated-measures ANOVA revealed a significant group-by-time interaction for LA diameter (p = 0.0017), while similar trends were observed for LAA (p = 0.0645) and LAS-R (p = 0.0547). No significant interaction effects were observed for LAVI-derived parameters or other indices of LA mechanical function. Conclusions: In this preliminary exploratory study, CBA showed a tendency toward greater structural LA remodeling compared with RFCA during a 12-month follow-up. However, these findings should be interpreted with caution given the limited sample size and population heterogeneity. Larger prospective studies are warranted to validate these observations.
- Open Access
Ventricular Arrhythmias in Left Ventricular Assist Device Patients—Current Diagnostic and Therapeutic Considerations
Left ventricular assist devices (LVAD) are used in the treatment of advanced left ventricular heart failure. LVAD can serve as a bridge to orthotopic heart transplantation or as a destination therapy in cases where orthotopic heart transplantation is contraindicated. Ventricular arrhythmias are frequently observed in patients with LVAD. This problem is further compounded as a result of diagnostic difficulties arising from presently available electrocardiographic methods. Due to artifacts from LVAD-generated electromagnetic fields, it can be challenging to assess the origin of arrhythmias in standard ECG tracings. In this article, we will review and discuss common mechanisms, diagnostics methods, and therapeutic strategies for ventricular arrhythmia treatment, as well as numerous problems we face in LVAD implant patients.
Open AccessVentricular Arrhythmias in Left Ventricular Assist Device Patients—Current Diagnostic and Therapeutic Considerations
Left ventricular assist devices (LVAD) are used in the treatment of advanced left ventricular heart failure. LVAD can serve as a bridge to orthotopic heart transplantation or as a destination therapy in cases where orthotopic heart transplantation is contraindicated. Ventricular arrhythmias are frequently observed in patients with LVAD. This problem is further compounded as a result of diagnostic difficulties arising from presently available electrocardiographic methods. Due to artifacts from LVAD-generated electromagnetic fields, it can be challenging to assess the origin of arrhythmias in standard ECG tracings. In this article, we will review and discuss common mechanisms, diagnostics methods, and therapeutic strategies for ventricular arrhythmia treatment, as well as numerous problems we face in LVAD implant patients.